GILD

Gilead Sciences Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth 9/10
  • Momentum 7/10
Gilead Sciences sales and earnings growth
GILD Growth
Great
  • Revenue Y/Y 2.78%
  • EPS Y/Y 6410.00%
  • FCF Y/Y -2.85%
Gilead Sciences gross and profit margin trends
GILD Profitability
Good
  • Gross margin 78.70%
  • EPS margin 27.90%
  • ROIC 30.30%
Gilead Sciences recent dividend growth
GILD Dividends
  • Dividend yield 2.11%
  • Growth 3Y 2.65%
  • Payout ratio 48%
Gilead Sciences net debt vs free cash flow
GILD Risk
Good
  • Debt / Equity 1.2
  • Debt / FCF 1.9
  • Interest coverage 10.7

Gilead Sciences stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Drug Manufacturers - General stocks ↗